Indefinite Delivery Contract SPE2DR25D9315

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which runs through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

This IDC is part of the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition strategy. The purpose of this $30.3 billion unrestricted and fully competitive program is to establish Prime Vendor Contracts that will provide worldwide pharmaceutical support to Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet, including the Hospital Ships USNS Mercy and USNS Comfort. The contracts will have a 30-month base period and three 30-month option periods, with awards made on a regional basis to at least three different contractors.